Merck

RAYMOND GILMARTIN, CHAIRMAN, PRESIDENT AND CEO, MERCK: Merck believed wholeheartedly in Vioxx.

CNN Transcript Nov 19, 2004 2004

RAYMOND GILMARTIN, CHAIRMAN, PRESIDENT AND CEO, MERCK: Merck believed wholeheartedly in Vioxx.

CNN Transcript Nov 19, 2004 2004

Inc. ( "Merck") (NYSE: MRK) will combine, under the name Merck, in a stock and cash transaction (the "Merger").

unknown title 2009

Merck is still awaiting an FDA decision in the U.S.

Novartis Unveils M.S. Drug Pricing Jeanne Whalen 2010

Does she think that Merck is paying me to speak about vaccines?

The Volokh Conspiracy » Interesting Libel Decision Arising from the Vaccine / Autism Debate 2010

Merck is not recommended at this time, holding a Dividend. com DARS Rating of 3.4 out of 5 stars.

Merck Is No Medicine In This Market Tom Reese 2010

You could sell the stock and buy the Health Care Select Sector SPDR ETF, which recently had just over 9% of assets in Merck shares, or Vanguard Health Care ETF, where Merck represents almost 8% of the portfolio.

Tax-Saving Trades Jonathan Burton 2010

Aside from trying to put the Vioxx case behind it, Merck is busy integrating its November 2009 acquisition of Schering-Plough for $49.6 billion.

Merck's Profit Takes Hit From Vioxx Charge Peter Loftus 2010

"One year later, Merck is a much stronger, unified organization that is well-positioned for the future," Merck Chief Executive Richard Clark said in a press release.

Merck's Profit Takes Hit From Vioxx Charge Peter Loftus 2010

Yesterday's $47.5 million verdict against Merck is the topic of a long weblog post by the plaintiff's son-in-law, Fredric Woodbridge, a self-described "political conservative" --

The Legal Underground: 2007